Poseida

Poseida is a California-based biopharmaceutical company that develops and commercializes gene therapies for the treatment of cancer and genetic diseases.

Business Model:

Revenue: $151.7M

Employees: 201-500

Detailed Poseida Information

Geographic Data

Poseida headquarters map

Address: 9390 Towne Centre Drive

City: San Diego

State: CA

Zip: 92121

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$70M

Raised Total:

$410M

Metrics

1,954,149Website Global Rank

10,901Website Monthly Traffic

Twitter Followers

Description

Poseida is a California-based biopharmaceutical company that develops and commercializes gene therapies for the treatment of cancer and genetic diseases.

Contact Phone:
+18587793100

Contact Email:

Poseida went public on 7/9/2020 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
7/9/2020

IPO Valuation:
$989M

Ticker Symbol:
PSTX

IPO Price:
$16/share

Amount Raised:
$224M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
6/2020 Series D 3 $110M Schonfeld Strategic Advisors
Fidelity Management and Research Company
Adage Capital Management
Fidelity Management and Research Company
Schonfeld Strategic Advisors
Fidelity Management and Research Company
Adage Capital Management
Fidelity Management and Research Company
4/2019 Series C $0 Longitude Capital
Malin Corporation
Perceptive Advisors
Boxer Capital
Aisling Capital
Pentwater Capital Management
Rapha Capital Management
Novartis
Vivo Capital
Longitude Capital
Malin Corporation
Perceptive Advisors
Boxer Capital
Aisling Capital
Pentwater Capital Management
Rapha Capital Management
Novartis
Vivo Capital
7/2018 Grant 1 $4M California Institute for Regenerative Medicine
California Institute for Regenerative Medicine
10/2017 Grant 1 $19.8M California Institute for Regenerative Medicine
California Institute for Regenerative Medicine
4/2018 Series B $30.5M Longitude Capital.
Vivo Capital
Tavistock Group
Malin Corporation plc
8/2022 Post-IPO Equity $70M
12/2015 Series A $0 Malin Corporation
Eric Ostertag
Malin Corporation
Eric Ostertag
4/2018 Series B $0 Longitude Capital
Malin Corporation
Tavistock Life Sciences
Vivo Capital
Longitude Capital
Malin Corporation
Tavistock Life Sciences
Vivo Capital
8/2017 Series A $0 Malin Corporation
Eric Ostertag
Malin Corporation
Eric Ostertag
7/2020 IPO $224M
8/2022 Post-IPO Equity $80.5M
3/2019 Series C $142M Novartis Pharma AG
4/2019 Series C 9 $142M Longitude Capital
Malin Corporation
Perceptive Advisors
Boxer Capital
Aisling Capital
Pentwater Capital Management
Rapha Capital Management
Novartis
Longitude Capital
Malin Corporation
Perceptive Advisors
Boxer Capital
Aisling Capital
Pentwater Capital Management
Rapha Capital Management
Novartis
4/2018 Series B 4 $30.5M Longitude Capital
Longitude Capital
8/2017 Series A 2 $11.2M Malin Corporation
Malin Corporation
12/2015 Series A 2 $23M Malin Corporation
Malin Corporation
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research